Stock Price
1.95
Daily Change
0.18 10.17%
Monthly
42.34%
Yearly
-17.72%
Q1 Forecast
1.82

Geron reported $-0.03 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -0.03 -0.04 Feb/25 2026
FY2025Q3 Sep/2025 -0.03 -0.03 -0.04 Nov/05 2025
FY2025Q2 Jun/2025 -0.02 -0.03 -0.10 Aug/06 2025
FY2025Q1 Mar/2025 -0.03 -0.03 -0.09 May/07 2025
FY2024Q4 Dec/2024 -0.04 -0.03 -0.09 Feb/26 2025




Eps Change Date
Amgen USD 5.29 0.35 Dec/2025
Bio Techne USD 0.46 0.04 Dec/2025
Cassava Sciences USD -0.22 0.7 Sep/2025
Cytokinetics USD -2.55 1.43 Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 0.97 0.19 Dec/2025
Genmab DKK 34.31 14.07 Jun/2025
Geron USD -0.03 0.01 Sep/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
MacroGenics USD 0.27 0.84 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Novavax USD -0.76 1.76 Sep/2024